|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:AKR1A1-C19orf53 (FusionGDB2 ID:3428) |
Fusion Gene Summary for AKR1A1-C19orf53 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: AKR1A1-C19orf53 | Fusion gene ID: 3428 | Hgene | Tgene | Gene symbol | AKR1A1 | C19orf53 | Gene ID | 10327 | 28974 |
| Gene name | aldo-keto reductase family 1 member A1 | chromosome 19 open reading frame 53 | |
| Synonyms | ALDR1|ALR|ARM|DD3|HEL-S-6 | HSPC023|LYDG10 | |
| Cytomap | 1p34.1 | 19p13.13 | |
| Type of gene | protein-coding | protein-coding | |
| Description | aldo-keto reductase family 1 member A1HEL-S-165mPalcohol dehydrogenasealdehyde reductasedihydrodiol dehydrogenase 3epididymis secretory protein Li 6epididymis secretory sperm binding protein Li 165mPglucuronate reductaseglucuronolactone reductase | leydig cell tumor 10 kDa protein homolog | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | P14550 | Q9UNZ5 | |
| Ensembl transtripts involved in fusion gene | ENST00000351829, ENST00000372070, ENST00000471651, ENST00000473038, | ENST00000588234, ENST00000593274, | |
| Fusion gene scores | * DoF score | 7 X 7 X 4=196 | 4 X 4 X 5=80 |
| # samples | 7 | 5 | |
| ** MAII score | log2(7/196*10)=-1.48542682717024 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/80*10)=-0.678071905112638 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: AKR1A1 [Title/Abstract] AND C19orf53 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | AKR1A1(46032692)-C19orf53(13888866), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | AKR1A1-C19orf53 seems lost the major protein functional domain in Hgene partner, which is a cell metabolism gene due to the frame-shifted ORF. AKR1A1-C19orf53 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | AKR1A1 | GO:0044597 | daunorubicin metabolic process | 18276838 |
| Hgene | AKR1A1 | GO:0044598 | doxorubicin metabolic process | 18276838 |
| Fusion gene breakpoints across AKR1A1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across C19orf53 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | STAD | TCGA-CG-5721-01A | AKR1A1 | chr1 | 46032692 | + | C19orf53 | chr19 | 13888866 | + |
Top |
Fusion Gene ORF analysis for AKR1A1-C19orf53 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000351829 | ENST00000588234 | AKR1A1 | chr1 | 46032692 | + | C19orf53 | chr19 | 13888866 | + |
| Frame-shift | ENST00000351829 | ENST00000593274 | AKR1A1 | chr1 | 46032692 | + | C19orf53 | chr19 | 13888866 | + |
| Frame-shift | ENST00000372070 | ENST00000588234 | AKR1A1 | chr1 | 46032692 | + | C19orf53 | chr19 | 13888866 | + |
| Frame-shift | ENST00000372070 | ENST00000593274 | AKR1A1 | chr1 | 46032692 | + | C19orf53 | chr19 | 13888866 | + |
| Frame-shift | ENST00000471651 | ENST00000588234 | AKR1A1 | chr1 | 46032692 | + | C19orf53 | chr19 | 13888866 | + |
| In-frame | ENST00000471651 | ENST00000593274 | AKR1A1 | chr1 | 46032692 | + | C19orf53 | chr19 | 13888866 | + |
| intron-3CDS | ENST00000473038 | ENST00000588234 | AKR1A1 | chr1 | 46032692 | + | C19orf53 | chr19 | 13888866 | + |
| intron-3CDS | ENST00000473038 | ENST00000593274 | AKR1A1 | chr1 | 46032692 | + | C19orf53 | chr19 | 13888866 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000471651 | AKR1A1 | chr1 | 46032692 | + | ENST00000593274 | C19orf53 | chr19 | 13888866 | + | 1277 | 866 | 1077 | 553 | 174 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000471651 | ENST00000593274 | AKR1A1 | chr1 | 46032692 | + | C19orf53 | chr19 | 13888866 | + | 0.12127849 | 0.87872154 |
Top |
Fusion Genomic Features for AKR1A1-C19orf53 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| AKR1A1 | chr1 | 46032692 | + | C19orf53 | chr19 | 13888865 | + | 5.55E-09 | 1 |
| AKR1A1 | chr1 | 46032692 | + | C19orf53 | chr19 | 13888865 | + | 5.55E-09 | 1 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
 |
Top |
Fusion Protein Features for AKR1A1-C19orf53 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr1:46032692/chr19:13888866) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| AKR1A1 | C19orf53 |
| FUNCTION: Catalyzes the NADPH-dependent reduction of a wide variety of carbonyl-containing compounds to their corresponding alcohols. Displays enzymatic activity towards endogenous metabolites such as aromatic and aliphatic aldehydes, ketones, monosaccharides and bile acids, with a preference for negatively charged substrates, such as glucuronate and succinic semialdehyde (PubMed:10510318). Functions as a detoxifiying enzyme by reducing a range of toxic aldehydes. Reduces methylglyoxal and 3-deoxyglucosone, which are present at elevated levels under hyperglycemic conditions and are cytotoxic. Involved also in the detoxification of lipid-derived aldehydes like acrolein (By similarity). Plays a role in the activation of procarcinogens, such as polycyclic aromatic hydrocarbon trans-dihydrodiols, and in the metabolism of various xenobiotics and drugs, including the anthracyclines doxorubicin (DOX) and daunorubicin (DAUN) (PubMed:18276838, PubMed:11306097). Displays no reductase activity towards retinoids (By similarity). {ECO:0000250|UniProtKB:P50578, ECO:0000250|UniProtKB:P51635, ECO:0000269|PubMed:10510318, ECO:0000269|PubMed:11306097, ECO:0000269|PubMed:18276838}. | FUNCTION: May have a potential role in hypercalcemia of malignancy. {ECO:0000250}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | AKR1A1 | chr1:46032692 | chr19:13888866 | ENST00000351829 | + | 4 | 9 | 21_23 | 118 | 326.0 | Nucleotide binding | NADP |
| Hgene | AKR1A1 | chr1:46032692 | chr19:13888866 | ENST00000372070 | + | 5 | 10 | 21_23 | 118 | 326.0 | Nucleotide binding | NADP |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | AKR1A1 | chr1:46032692 | chr19:13888866 | ENST00000351829 | + | 4 | 9 | 162_163 | 118 | 326.0 | Nucleotide binding | NADP |
| Hgene | AKR1A1 | chr1:46032692 | chr19:13888866 | ENST00000351829 | + | 4 | 9 | 210_217 | 118 | 326.0 | Nucleotide binding | NADP |
| Hgene | AKR1A1 | chr1:46032692 | chr19:13888866 | ENST00000351829 | + | 4 | 9 | 261_273 | 118 | 326.0 | Nucleotide binding | NADP |
| Hgene | AKR1A1 | chr1:46032692 | chr19:13888866 | ENST00000372070 | + | 5 | 10 | 162_163 | 118 | 326.0 | Nucleotide binding | NADP |
| Hgene | AKR1A1 | chr1:46032692 | chr19:13888866 | ENST00000372070 | + | 5 | 10 | 210_217 | 118 | 326.0 | Nucleotide binding | NADP |
| Hgene | AKR1A1 | chr1:46032692 | chr19:13888866 | ENST00000372070 | + | 5 | 10 | 261_273 | 118 | 326.0 | Nucleotide binding | NADP |
Top |
Fusion Gene Sequence for AKR1A1-C19orf53 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >3428_3428_1_AKR1A1-C19orf53_AKR1A1_chr1_46032692_ENST00000471651_C19orf53_chr19_13888866_ENST00000593274_length(transcript)=1277nt_BP=866nt CTTAAGCTGAGGATCGTTGGATCTCTGGCGGGGTGCAGAACTGAGCCCAGGCCACAGTACCCTATTCACGCTCTGTGCTTGTGCCAAGGG GGCAATGGCGGCTTCCTGTGTTCTACTGCACACTGGGCAGAAGATGCCTCTGATTGGTCTGGGTACCTGGAAGAGTGAGCCTGGTCAGGT AAAAGCAGCTGTTAAGTATGCCCTTAGCGTAGGCTACCGCCACATTGATTGTGCTGCTATCTACGGCAATGAGCCTGAGATTGGGGAGGC CCTGAAGGAGGACGTGGGACCAGGCAAGGTGAGCCTTGCCAGAGCCTCATCTGGGGAATCAGGGGGTTGAGCAGGATGGTGTTAGTAACT TATTGTAAGTCACAGCAGCAGAGCAGGATAGGAACACTCATTTGCATGCCAAGCTGAGGAGCTTGACATGGGATCTTAGCCTCTTCTGCT ACAGCAGCTTAGCTGTAGCTACAGGAGTTTAACTCTGGAAAAAGGAAGGCAGTCTCACATGGTGTGTACCCCAGGGTATGCACCTGTAAC CCTCCTGCTCCCTTTATTCATTTAGAAAAGGTGCTGACTTTTCTGTTGAGCACCTGGGGTTACAGTAATAAGTAAGTCTCAGCAGAAGAT GTGAGAAGAGCTCACCATTAGTGCCGTGCCCTGTGCTGGAAGAAGGGTGGATAACTCCCTGAGGATGAGTTAAGGAAGACTTCCTAGGGG AGAGGAGATATCTACGTCTAGGAAGAGGAGGGGGCATAGGCATTCCATGTAAACTTAACACCTGGGTTACGATCTGGAAGGATGAAAAAG CATGGCTTTTTTTGGCCAGGCGCGGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAACCTAGAAGTCGGAATCCGGAAGAAGATCGAAC ATGACGTGGTGATGAAAGCCAGCAGCAGCCTGCCCAAGAAGCTGGCACTGCTGAAGGCCCCAGCCAAGAAGAAAGGGGCAGCTGCCGCCA CCTCCTCCAAGACACCTTCCTGAGGACGCTGGCCCCAGTGCAGGCCAACATCCCACCCCCTACCTCCATATGGGACCTTGCAAGTCATCC CACAGGCTGCACTGTCAGGAAGAGGACCCTGTCCCCCAGCACTGGGCTTCACCTAGAACTTCAGTGGGGGCCAAGGGTGCTGAGAACCCA GCAATGACCAGGAAGATACAGTCACTAACTTCATCTGTCCCCGTGCCCCTTCCCAGGTCCTGCCTCCACAGGTTTAACCCAGAACAATAA >3428_3428_1_AKR1A1-C19orf53_AKR1A1_chr1_46032692_ENST00000471651_C19orf53_chr19_13888866_ENST00000593274_length(amino acids)=174AA_BP=0 MTCKVPYGGRGWDVGLHWGQRPQEGVLEEVAAAAPFFLAGAFSSASFLGRLLLAFITTSCSIFFRIPTSRFPKCWDYRREPPRLAKKSHA -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for AKR1A1-C19orf53 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for AKR1A1-C19orf53 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for AKR1A1-C19orf53 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies